Find information on thousands of medical conditions and prescription drugs.

Fumagillin

Fumagillin is an antibiotic originally used against fungal Nosema apis infections in honeybees. Later, some studies found it to be effective against some myxozoan parasites, including Myxobolus cerebralis, an important parasite of fish; however, in the more rigorous tests required for U.S. Food and Drug Administration approval, it was found to be ineffective. more...

more...

Reference

Read more at Wikipedia.org
• [List your site here Free!]


Mechanisms and Limits of Induced Postnatal Lung Growth
INTRODUCTION The mature lung has traditionally been assumed to be nonmalleable; structural changes were considered irreversible once normal alveolar development ...
From American Journal of Respiratory and Critical Care Medicine, 8/1/04
Antivascular therapy: a new approach to cancer treatment
The growth of tumors is dependent on angiogenesis -- the development of new blood vessels (neovascularization) to feed the tumor and enable it to grow, ...
From British Medical Journal, 3/27/99 by A J Hayes
Vascular Endothelial Growth Factor Increased by Pulmonary Surgery Accelerates the Growth of Micrometastases in Metastatic Lung Cancer - )
Background: The use of surgery for metastatic lung cancer has been established recently and the indications have been extended to multiple and bilateral ...
From CHEST, 12/1/98 by Yoshimasa Maniwa
Identification of the Microsporidian Encephalitozoon hellem using immunoglobulin G monoclonal antibodies
Objective.-Microsporidia isolated from clinical specimens so far have been identified to level of species by electron microscopy, indirect immunofluorescence ...
From Archives of Pathology & Laboratory Medicine, 2/1/98 by Croppo, Gian Piero
PRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on PPI-2458
WALTHAM, Mass. -- PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today announced that it presented preclinical data on its investigational compound, ...
From Business Wire, 9/21/05
PRAECIS PHARMACEUTICALS INCORPORATED Announces Publication of Preclinical Data on PPI-2458 in Rheumatoid Arthritis
WALTHAM, Mass. -- PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS), today announced the publication of preclinical research results relating to the ...
From Business Wire, 7/20/04
PRAECIS PHARMACEUTICALS INCORPORATED Reports Fourth Quarter and Year End 2003 Financial Results
Business Editors/Health/Medical Writers WALTHAM, Mass.--(BUSINESS WIRE)--Jan. 30, 2004 PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today ...
From Business Wire, 1/30/04
PRAECIS PHARMACEUTICALS INCORPORATED Announces Collaboration with the National Cancer Institute's Division of Cancer Treatment and Diagnosis for the Development
Business Editors/Health/Medical Writers WALTHAM, Mass.--(BUSINESS WIRE)--Dec. 10, 2003 PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today ...
From Business Wire, 12/10/03

Home Contact Resources Exchange Links ebay